logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2020 — New hope for immunotherapy in early triple-negative breast cancer

Atezolizumab added to neoadjuvant chemotherapy is linked to improved pathological response.